Clinical Significance of T790M After Acquiring Resistance to Gefitinib or Erlotinib in Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Gene Mutation
2003 ◽
Vol 13
(5)
◽
pp. 289-298
◽
2010 ◽
Vol 137
(4)
◽
pp. 687-694
◽